Human cytomegalovirus antagonizes activation of Fcγ receptors by distinct and synergizing modes of IgG manipulation

© 2021, Kolb et al..

Human cytomegalovirus (HCMV) is endowed with multiple highly sophisticated immune evasion strategies. This includes the evasion from antibody mediated immune control by counteracting host Fc-gamma receptor (FcγR) mediated immune control mechanisms such as antibody-dependent cellular cytotoxicity (ADCC). We have previously shown that HCMV avoids FcγR activation by concomitant expression of the viral Fc-gamma-binding glycoproteins (vFcγRs) gp34 and gp68. We now show that gp34 and gp68 bind IgG simultaneously at topologically different Fcγ sites and achieve efficient antagonization of host FcγR activation by distinct but synergizing mechanisms. While gp34 enhances immune complex internalization, gp68 acts as inhibitor of host FcγR binding to immune complexes. In doing so, gp68 induces Fcγ accessibility to gp34 and simultaneously limits host FcγR recognition. The synergy of gp34 and gp68 is compelled by the interfering influence of excessive non-immune IgG ligands and highlights conformational changes within the IgG globular chains critical for antibody effector function.

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

eLife - 10(2021) vom: 16. März

Sprache:

Englisch

Beteiligte Personen:

Kolb, Philipp [VerfasserIn]
Hoffmann, Katja [VerfasserIn]
Sievert, Annika [VerfasserIn]
Reinhard, Henrike [VerfasserIn]
Merce-Maldonado, Eva [VerfasserIn]
Le-Trilling, Vu Thuy Khanh [VerfasserIn]
Halenius, Anne [VerfasserIn]
Gütle, Dominique [VerfasserIn]
Hengel, Hartmut [VerfasserIn]

Links:

Volltext

Themen:

Carrier Proteins
Cytomegalovirus
Fc receptors
Glycoproteins
Gp34 protein, cytomegalovirus
Immune evasion
Immunoglobulin
Immunoglobulin G
Immunology
Infectious disease
Inflammation
Journal Article
Membrane Glycoproteins
Microbiology
Natural killer cells
Receptors, IgG
Research Support, Non-U.S. Gov't
UL119-UL118 glycoprotein, Human cytomegalovirus
Viral Proteins
Virus

Anmerkungen:

Date Completed 25.08.2021

Date Revised 25.08.2021

published: Electronic

Citation Status MEDLINE

doi:

10.7554/eLife.63877

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM322808685